The survival of patients with SCLC has not improved until two studies (24, 30) (ie, CASPIAN and Impower133) showing the combination of PD-L1 inhibitors with chemotherapy has survival benefit versus chemotherapy alone. Here, CD274 is linked to small cell lung carcinoma.